BeStock  
Stocks › Biotechnology › ANNX

Annexon ANNX

US equityMarket cap rank #3499Biotechnology
$3.10 −$0.31 (-9.09%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.41 +10.00%
Open$3.37
Prev close$3.41
Day range$3.07 – $3.37
Volume4.46M
Market cap$591.37M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership108.2%-1.60 pts vs. prior quarter
Institutions holding248-6 vs. prior quarter
Insider trades (recent)34 buys / 16 sellsNet buying
Short interest15.29% of floatDays to cover 7.2 · as of 30 Oct 2026
Short-sale volume share21.2%5-day average of daily volume

Short-sale volume as % of daily volume

9%17%26%34%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.01M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$191.2KSuper−$1.2MBig−$2.7MMid−$4.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 39.2% of shares outstanding.

Largest holders

  • FMR14.11%
  • Redmile Group, LLC7.63%
  • BlackRock7.47%
  • Alerce Investment Management L.P.5.00%
  • State Street Global Advisors5.01%
  • BVF Partners L.P.4.56%
  • Vanguard Capital Management, LLC4.13%
  • Woodline Partners LP3.63%

By investor type

  • Mutual Fund55.37%
  • Hedge Fund32.34%
  • VC/PE Fund13.30%
  • Public Company4.46%
  • Insurance Company1.16%
  • Individual/Insider0.91%
  • Endowment Fund0.64%
  • Private Company0.50%

Reported short interest has fallen from 17.19% to 15.29% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +7,390,169 14.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +999,662 4.1%
BlackRock Mutual Fund 2026/Q3 +715,533 7.5%
Y-Intercept (Hong Kong) Limited Mutual Fund 2026/Q3 +562,650 0.7%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +483,844 0.9%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +477,446 0.3%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +427,100 1.0%
Redmile Group, LLC Hedge Fund 2026/Q3 +2,679,019 7.6%
FMR Mutual Fund 2026/Q3 +8,881,850 10.3%
Woodline Partners LP Hedge Fund 2026/Q3 +4,587,930 3.6%
MPM BioImpact LLC VC/PE Fund 2026/Q3 +3,544,354 1.9%
State Street Global Advisors Mutual Fund 2026/Q3 +2,905,066 5.2%
BlackRock Mutual Fund 2026/Q3 +2,601,235 7.1%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,912,568 1.7%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +1,760,131 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
23 Sep 2026 Douglas Love Chief Executive Officer Open Market Acquisition +26,065 $3.83 390,476
12 Aug 2026 Thomas Wiggans Former Independent Chairperson Intent to Sell (Form 144) -2,000 $5.30 –
9 Aug 2026 Mark Blumenkranz Director Other Derivative Acquisition +175,000 $5.39 175,000
14 Jul 2026 Thomas Wiggans Former Independent Chairperson Intent to Sell (Form 144) -2,000 $6.32 –
13 Jul 2026 Thomas Wiggans Former Independent Chairperson Intent to Sell (Form 144) -1,000 $5.61 –
10 Jun 2026 Muneer Satter Former Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
10 Jun 2026 Jung Choi Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
10 Jun 2026 William Waddill Interim Lead Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
10 Jun 2026 Ted Yednock Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board Derivative Exercise and Retained +30,646 $1.85 184,807
10 Jun 2026 William Jones Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
10 Jun 2026 William Carson Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
10 Jun 2026 Bettina Cockroft Independent Director Other Derivative Acquisition +65,000 $4.70 65,000
27 May 2026 Alerce Investment Management L.P. Open Market Acquisition +613,497 $5.41 9,534,894
10 May 2026 William Carson Independent Director Automatic Acquisition +8,000 $5.78 78,405
9 Apr 2026 William Carson Independent Director Automatic Acquisition +8,000 $6.20 70,405
9 Mar 2026 William Carson Independent Director Automatic Acquisition +8,000 $5.67 62,405
1 Mar 2026 Dean Artis Chief Scientific Officer & Executive VP Open Market Disposition -5,894 $5.43 74,618
1 Mar 2026 Ted Yednock Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board Open Market Disposition -5,566 $5.42 154,161
1 Mar 2026 Jennifer Lew Chief Financial Officer Open Market Disposition -5,565 $5.42 65,225
1 Mar 2026 Jamie Dananberg Chief Medical Officer Open Market Disposition -5,820 $5.43 24,357

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 28,984,850 15.3% 7.2
15 Oct 2026 31,627,401 16.7% 10.3
30 Sep 2026 32,009,914 16.9% 8.9
15 Sep 2026 32,871,995 17.3% 11.7
31 Aug 2026 32,094,286 16.9% 12.7
14 Aug 2026 32,583,299 17.2% 13.2

Discussion

No comments yet — be the first to weigh in on ANNX.

Sign in to join the discussion.

Scroll to Top